IO Biotech Inc.

NASDAQ: IOBT · Real-Time Price · USD
2.15
0.87 (67.97%)
At close: Aug 15, 2025, 3:59 PM
1.99
-7.40%
After-hours: Aug 15, 2025, 07:58 PM EDT

IO Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 1.11M 1.11M 1.11M 1.11M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
433K 644K 626K 820K 793K 756K 745K 551K 364K 190K n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-214K -425K 484K 290K 317K 354K -745K -551K -364K -190K n/a n/a n/a n/a n/a n/a n/a
Operating Income
-97.56M -95.18M -96.42M -93.4M -93.72M -91.44M -83.65M -76.03M -72.34M -71.42M -72.43M -63.61M -54.43M -41.23M -22.38M -18.77M -11.87M
Interest Income
3.52M 4.72M 5.95M 6.58M 6.47M 5.88M 4.71M 3.46M 2.42M 1.41M 630K 173K 15K n/a n/a n/a 4K
Pretax Income
-97.28M -94.05M -88.99M -87.3M -87.64M -85.23M -78.49M -71.94M -69.69M -70.19M -72.34M -61.23M -81.2M -67.81M -49.12M -48.15M -12.79M
Net Income
-98.45M -95.49M -90.34M -88M -88.5M -86.08M -79.97M -73.98M -71.3M -71.46M -72.7M -61.47M -81.33M -67.88M -49.12M -48.15M -13.3M
Selling & General & Admin
24.02M 23.69M 24.11M 23.61M 23.27M 23.41M 23.16M 23.17M 23.76M 24.44M 23.44M 20.51M 16.82M 11.08M 6.46M 4.2M 2.3M
Research & Development
73.55M 71.48M 72.11M 69.58M 70.24M 67.83M 60.49M 52.86M 48.58M 46.99M 48.99M 43.1M 37.61M 30.15M 15.92M 14.57M 9.57M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
97.56M 95.18M 96.22M 93.2M 93.52M 91.24M 83.65M 76.03M 72.34M 71.42M 72.43M 63.61M 54.43M 41.23M 22.38M 18.77M 12.78M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a 78K 180K 303K 454K 443K 412K 361K 221K 161K 90K
Selling & Marketing Expenses
n/a n/a -201K -201K -201K -201K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
74.98M 95.18M 96.42M 93.4M 93.72M 91.44M 83.65M 76.03M 72.34M 71.42M 72.43M 63.61M 54.43M 41.23M 22.38M 18.77M 12.78M
Income Tax Expense
1.17M 1.44M 1.35M 703K 861K 852K 1.49M 2.04M 1.61M 1.27M 353K 238K 205K 139K 82K 89K 18K
Shares Outstanding (Basic)
65.88M 65.88M 65.88M 65.88M 65.88M 65.88M 50.17M 28.82M 28.82M 28.82M 28.82M 28.82M 28.82M 25.73M 25.73M 11.55M 11.55M
Shares Outstanding (Diluted)
65.88M 65.88M 65.88M 65.88M 65.88M 65.88M 50.17M 28.82M 28.82M 28.82M 28.82M 28.82M 28.82M 25.73M 25.73M 11.55M 11.55M
EPS (Basic)
-1.49 -1.45 -1.37 -1.44 -1.86 -2.15 -2.45 -2.56 -2.47 -2.48 -2.61 -2.24 -4.92 -4.64 -4.03 -4.16 -20.67
EPS (Diluted)
-1.49 -1.45 -1.37 -1.44 -1.86 -2.15 -2.45 -2.56 -2.47 -2.48 -2.61 -2.24 -4.92 -4.64 -4.03 -4.16 -20.65
EBITDA
-96.93M -94.33M -93.23M -88.86M -89.2M -86.97M -80.23M -73.69M -70.31M -69.35M -71.55M -60.57M -80.57M -63.77M -42.68M -38.29M n/a
EBIT
-74.98M -95.18M -94.06M -89.68M -90M -87.72M -80.98M -74.36M -70.79M -69.88M -71.89M -60.79M -80.79M -67.45M -48.9M -47.99M -11.79M
Depreciation & Amortization
638K 849K 831K 820K 793K 756K 745K 670K 494K 540K 350.5K 230.5K 220.5K 3.81M 6.35M 9.78M 11.87M